Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early sepsis diagnosis via protein and miRNA biomarkers using a novel point-of-care photonic biosensor

  • Fabri Faja, Nuria|||0000-0002-6778-8467
  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • Dey, Priyanka|||0000-0002-7158-4491
  • Terborg, Roland A.
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Belushkin, Alexander|||0000-0003-1928-2223
  • Yesilköy, Filiz|||0000-0001-8483-3285
  • Duempelmann, Luc
  • Altug, Hatice|||0000-0001-5522-1343
  • Pruneri, Valerio
  • Lechuga, Laura M.|||0000-0001-5187-5358
Sepsis is a condition characterized by a severe stage of blood-infection often leading to tissue damage, organ failure and finally death. Fast diagnosis and identification of the sepsis stage (sepsis, severe sepsis or septic shock) is critical for the patient's evolution and could help in defining the most adequate treatment in order to reduce its mortality. The combined detection of several biomarkers in a timely, specific and simultaneous way could ensure a more accurate diagnosis. We have designed a new optical point-of-care (POC) device based on a phase-sensitive interferometric biosensor with a label-free microarray configuration for potential high-throughput evaluation of specific sepsis biomarkers. The sensor chip, which relies on the use of metallic nanostructures, provides versatility in terms of biofunctionalization, allowing the efficient immobilization of different kind of receptors such as antibodies or oligonucleotides. We have focused on two structurally different types of biomarkers: proteins, including C-reactive protein (CRP) and Interleukin 6 (IL6), and miRNAs, using miRNA-16 as an example. Limits of Detection (LoD) of 18 μg mL, 88 μg mL and 1 μM (6 μg mL) have been respectively obtained for CRP, IL6 and miRNA-16 in individual assays, with high accuracy and reproducibility. The multiplexing capabilities have also been assessed with the simultaneous analysis of both protein biomarkers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Label-free Bacteria Quantification in Blood Plasma by a Bioprinted Microarray Based Interferometric Point-of-Care Device

  • Dey, Priyanka|||0000-0002-7158-4491
  • Fabri Faja, Nuria|||0000-0002-6778-8467
  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • Terborg, Roland A.
  • Belushkin, Alexander|||0000-0003-1928-2223
  • Yesilköy, Filiz|||0000-0001-8483-3285
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • Ruiz Rodríguez, Juan Carlos
  • Ferrer, Ricard|||0000-0002-4859-4747
  • González-López, Juanjo|||0000-0003-2419-5909
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Altug, Hatice|||0000-0001-5522-1343
  • Pruneri, Valerio
  • Lechuga, Laura M.|||0000-0001-5187-5358
Existing clinical methods for bacteria detection lack speed, sensitivity, and, importantly, point-of-care (PoC) applicability. Thus, finding ways to push the sensitivity of clinical PoC biosensing technologies is crucial. Here we report a portable PoC device based on lens-free interferometric microscopy (LIM). The device employs high performance nanoplasmonics and custom bioprinted microarrays and is capable of direct label-free bacteria (E. coli) quantification. With only one-step sample handling we offer a sample-to-data turnaround time of 40 min. Our technology features detection sensitivity of a single bacterial cell both in buffer and in diluted blood plasma and is intrinsically limited by the number of cells present in the detection volume. When employed in a hospital setting, the device has enabled accurate categorization of sepsis patients (infectious SIRS) from control groups (healthy individuals and noninfectious SIRS patients) without false positives/negatives. User-friendly on-site bacterial clinical diagnosis can thus become a reality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fast and accurate pneumocystis pneumonia diagnosis in human samples using a label-free plasmonic biosensor

  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • Aviñó, Ana|||0000-0003-3047-738X
  • Friaza, Vicente|||0000-0002-2900-4334
  • Medina Escuela, Alfonso
  • Huertas, César S.|||0000-0002-3100-4034
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • Eritja, Ramon|||0000-0001-5383-9334
  • Lechuga, Laura M.|||0000-0001-5187-5358
Pneumocystis jirovecii is a fungus responsible for human Pneumocystis pneumonia, one of the most severe infections encountered in immunodepressed individuals. The diagnosis of Pneumocystis pneumonia continues to be challenging due to the absence of specific symptoms in infected patients. Moreover, the standard diagnostic method employed for its diagnosis involves mainly PCR-based techniques, which besides being highly specific and sensitive, require specialized personnel and equipment and are time-consuming. Our aim is to demonstrate an optical biosensor methodology based on surface plasmon resonance to perform such diagnostics in an efficient and decentralized scheme. The biosensor methodology employs poly-purine reverse-Hoogsteen hairpin probes for the detection of the mitochondrial large subunit ribosomal RNA (mtLSU rRNA) gene, related to P. jirovecii detection. The biosensor device performs a real-time and label-free identification of the mtLSU rRNA gene with excellent selectivity and reproducibility, achieving limits of detection of around 2.11 nM. A preliminary evaluation of clinical samples showed rapid, label-free and specific identification of P. jirovecii in human lung fluids such as bronchoalveolar lavages or nasopharyngeal aspirates. These results offer a door for the future deployment of a sensitive diagnostic tool for fast, direct and selective detection of Pneumocystis pneumonia disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Ultrasensitive label-free detection of unamplified multidrug-resistance bacteria genes with a bimodal waveguide interferometric biosensor

  • Maldonado, Jesús
  • González-Guerrero, Ana Belén|||0000-0002-4871-9642
  • Fernandez-Gavela, Adrian|||0000-0002-4562-1308
  • González-López, Juanjo|||0000-0003-2419-5909
  • Lechuga, Laura M.|||0000-0001-5187-5358
Infections by multidrug-resistant bacteria are becoming a major healthcare emergence with millions of reported cases every year and an increasing incidence of deaths. An advanced diagnostic platform able to directly detect and identify antimicrobial resistance in a faster way than conventional techniques could help in the adoption of early and accurate therapeutic interventions, limiting the actual negative impact on patient outcomes. With this objective, we have developed a new biosensor methodology using an ultrasensitive nanophotonic bimodal waveguide interferometer (BiMW), which allows a rapid and direct detection, without amplification, of two prevalent and clinically relevant Gram-negative antimicrobial resistance encoding sequences: the extended-spectrum betalactamase-encoding gene blaCTX-M-15 and the carbapenemase-encoding gene blaNDM-5 We demonstrate the extreme sensitivity and specificity of our biosensor methodology for the detection of both gene sequences. Our results show that the BiMW biosensor can be employed as an ultrasensitive (attomolar level) and specific diagnostic tool for rapidly (less than 30 min) identifying drug resistance. The BiMW nanobiosensor holds great promise as a powerful tool for the control and management of healthcare-associated infections by multidrug-resistant bacteria.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-step immobilization of antibodies and DNA on gold sensor surfaces via a poly-adenine oligonucleotide approach

  • Huertas, César S.|||0000-0002-3100-4034
  • Soler Aznar, Maria|||0000-0001-7232-2277
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Lechuga, Laura M|||0000-0001-5187-5358
Label-free plasmonic biosensors have demonstrated promising capabilities as analytical tools for the detection of virtually any type of biomarker. They are presented as good candidates for precision diagnostics since they offer highly sensitive, cost-effective solutions that can be used in any clinical or laboratory setting without the need for specialized trainees. However, different surface functionalization protocols are required, depending on the nature of the biorecognition element, limiting their capabilities for integrated multi-biomarker detection. Here, we present a simple, yet efficient, one-step immobilization approach that is common for both DNA probes and antibodies. Our immobilization approach relies on the incorporation of poly-adenine (polyA) blocks in both nucleic acid probes and antibodies. PolyA sequences have a remarkable affinity for gold surfaces and can specifically interact with sufficient strength to generate stable, dense, and highly ordered monolayers. We have demonstrated excellent performance of our universal functionalization method, showing limits of detection and quantification in the pM-nM range. Moreover, it was able to reduce up to 50% of the background signal from undiluted serum samples compared to conventional methods, demonstrating the immense potential of this strategy for the direct analysis of human biofluids, essential for rapid point-of-care diagnostics. The polyA-based immobilization approach is a promising alternative for the generation of multiplexed biosensors that can detect both protein and nucleic acid biomarkers for multiparametric diagnostic assays.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis

  • Prada, Y. A.|||0000-0003-2873-7103
  • Soler Aznar, Maria|||0000-0001-7232-2277
  • Guzmán, Fanny|||0000-0002-7829-0568
  • Castillo, John J.
  • Lechuga, Laura M|||0000-0001-5187-5358
  • Mejía-Ospino, Enrique|||0000-0001-9599-7891
Cutaneous leishmaniasis (CL) is one of the illnesses caused by Leishmania parasite infection, which can be asymptomatic or severe according to the infecting Leishmania strain. CL is commonly diagnosed by directly detecting the parasites or their DNA in tissue samples. New diagnostic methodologies target specific proteins (biomarkers) secreted by the parasite during the infection process. However, specific bioreceptors for the in vivo or in vitro detection of these novel biomarkers are rather limited in terms of sensitivity and specificity. For this reason, we here introduce three novel peptides as bioreceptors for the highly sensitive and selective identification of acid phosphatase (sAP) and proteophosphoglycan (PPG), which have a crucial role in leishmaniasis infection. These high-affinity peptides have been designed from the conservative domains of the lectin family, holding the ability to interact with the biological target and produce the same effect than the original protein. The synthetic peptides have been characterized and the affinity and kinetic constants for their interaction with the targets (sAP and PPG) have been determined by a surface plasmon resonance biosensor. Values obtained for KD are in the nanomolar range, which is comparable to high-affinity antibodies, with the additional advantage of a high biochemical stability and simpler production. Pep2854 exhibited a high affinity for sAP (KD = 1.48 nM) while Pep2856 had a good affinity for PPG (KD 1.76 nM). This study evidences that these peptidomimetics represent a novel alternative tool to the use of high molecular weight proteins for biorecognition in the diagnostic test and biosensor devices for CL.